News
Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era.
The agency has provided few details about its AI pilot as it makes moves on its “aggressive timeline” for rollout.
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...
The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool's ...
The Food and Drug Administration has officially launched "Elsa," a generative artificial intelligence platform designed to ...
6d
Amazon S3 on MSNFDA Launches ELSA: AI to Revolutionize Drug Approval ProcessThe FDA has introduced ELSA, a groundbreaking AI tool designed to expedite the review process for drugs and medical devices.
The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets.
The U.S. FDA announced this week that it deployed a generative AI tool called ELSA, now in use by staff across the agency, ...
Tonight’s the premiere of Dimension 20’s steampunk-themed Cloudward, Ho! series. I’m excited; anyone else? (If you’re ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results